Lexicon Pharma (LXRX) Announces Acquisition of Exclusive LX9211 Rights
Go back to Lexicon Pharma (LXRX) Announces Acquisition of Exclusive LX9211 Rights| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 44.70 -4.16 (8.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.86 | 52 Week High | $77.12 | |||
| Open | $47.39 | 52 Week Low | $49.03 | |||
| Day High | $47.50 | P/E | 29.03 | |||
| Day Low | $44.37 | EPS | $1.54 | |||
| Volume | 45,094,676 | |||||
| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 1.54 -0.06 (3.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.60 | 52 Week High | $19.62 | |||
| Open | $1.59 | 52 Week Low | $7.65 | |||
| Day High | $1.59 | P/E | N/A | |||
| Day Low | $1.52 | EPS | $-0.22 | |||
| Volume | 1,685,915 | |||||
